Viewing Study NCT05725213



Ignite Creation Date: 2024-05-06 @ 6:37 PM
Last Modification Date: 2024-10-26 @ 2:51 PM
Study NCT ID: NCT05725213
Status: COMPLETED
Last Update Posted: 2024-02-23
First Post: 2023-01-19

Brief Title: ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis
Sponsor: Galderma Laboratorium GmbH
Organization: Galderma Laboratorium GmbH

Study Overview

Official Title: Non-interventional Study Investigating Photodynamic Therapy With Artificial Daylight Under Routine Clinical Conditions in Patients With Actinic Keratosis ArtLight
Status: COMPLETED
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The objective of this non-interventional study NIS is to gain comprehensive insights into the practicability of ADL-PDT with Metvix in patients with actinic keratoses under real-world conditions
Detailed Description: The objective of this non-interventional study NIS is to gain comprehensive insights into the practicability of ADL-PDT with Metvix in patients with actinic keratoses under real-world conditions Furthermore this NIS will document the efficacy satisfaction safety and tolerability of ADL-PDT with Metvix in routine use according to the label

The observational study is designed as a multicenter study covering all parts of Germany Participating investigators are dermatologists experienced in ADL-PDT with an adequate pool of patients with actinic keratoses The observation time per patient will comprise up to 6 months including up to 4 visits

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None